Abstract
Protein carbonyl levels, a measure of protein oxidation, were found to be significantly elevated (p < 0.0005) in the sera of chronic fatigue syndrome (CFS) patients vs. controls. In contrast, the total protein levels in sera CFS patients were unchanged from those of controls. The elevated protein carbonyl levels confirm earlier reports suggesting that oxidative stress is associated with chronic fatigue syndrome and are consistent with a prediction of the elevated nitric oxide/peroxynitrite theory of chronic fatigue syndrome and related conditions.
References
Fukuda K, Stauss SE, Hickie I, Sharpe MC, Dobbin JG, Komaroff A: The chronic fatigue syndrome: A comprehensive approach to its definition and study. International Chronic Fatigue Syndrome Group. Ann Intern Med 121: 953-959, 1994
Whiteside TL, Friberg D: Natural killer cells and natural killer cell activity in chronic fatigue syndrome. Am J Med 105: 27S-34S, 1998
Patarca R: Cytokines and chronic fatigue syndrome. Ann NY Acad Sci 933: 185-200, 2001
Komaroff AL, Buchwald DS: Chronic fatigue syndrome: An update. Ann Rev Med 49: 1-13, 1998
Patarca-Montero R, Mark T, Fletcher MA, Klimas NG: Immunology of chronic fatigue syndrome. J Chronic Fatigue Syndr 6: 69-108, 2000
Rowe PC, Barron DF, Calkins H, Maumenee IH, Tong PY, Geraghty MT: Orthostatic intolerance and chronic fatigue syndrome associated with Ehlers-Danlos syndrome. J Pediatr 135: 494-499, 1999
Stewart JM: Orthostatic intolerance: A review with application to the chronic fatigue syndrome. J Chronic Fatigue Syndr 8: 45-64, 2001
Shetzline SE, Martinand-Marie C, Reichenbach NL, Buletic Z, Lebleu B, Pfleiderer W, Charubala R, De Meirlier K, De Becker P, Peterson DL, Herst CV, Englebienne P, Suhadolnik RJ: Structural and functional features of the 37-kDa 2-5A-dependent RNase L in chronic fatigue syndrome. J Interferon Cytokine Res 22: 443-456, 2002
Pall ML: Elevated, sustained peroxynitrite levels as the cause of chronic fatigue syndrome. Med Hypoth 54: 115-125, 2000
Pall ML: Elevated peroxynitrite as the cause of chronic fatigue syndrome: Other inducers and mechanisms of symptom generation. J Chronic Fatigue Syndr 7: 45-58, 2000
Pall ML: Cobalamin used in chronic fatigue syndrome therapy is a nitric oxide scavenger. J Chronic Fatigue Syndr 8: 39-44, 2000
Fulle S, Mecocci P, Fano G, Vecchiet I, Vecchini A, Racciotti D, Cherubini A, Pizzigallo E, Vecchiet L, Senin U, Beal MF: Specific oxidative alterations in vastus lateralis muscle of patients with the diagnosis of chronic fatigue syndrome. Free Radic Biol Med 15: 1252-1259, 2000
Richards RS, Roberts TK, Mathers MB, Dunstan RH, McGregor NR, Butt HL: Investigation of erythrocyte oxidative damage in rheumatoid arthritis and chronic fatigue syndrome. J Chronic Fatigue Syndr 6: 37-46, 2000
Richards RS, Roberts TK, McGregor NR, Dunstan RH, Butt HL: Blood parameters indicative of oxidative stress are associated with symptom expression in chronic fatigue syndrome. Redox Rep 5: 35-41, 2000
Keenoy BM, Moorkens G, Vertommen J, DeLeeuw I: Antioxidant status and lipoprotein oxidation in chronic fatigue syndrome. Life Sci 68: 2037-2049, 2001
Logan AC, Wong C: Chronic fatigue syndrome: Oxidative stress and dietary modifications. Altern Med Rev 6: 450-459, 2001
Rigden S, Barrager E, Bland JS: Evaluation of the effect of a modified entero-hepatic resuscitation program in chronic fatigue syndrome patients. J Adv Med 11: 247-262, 1998
Stadtman ER, Levine RL: Protein oxidation. Ann NY Acad Sci 899: 191-208, 2000
Levine RL, Garland D, Oliver CN, Amici A, Climent I, Lenz AG, Ahn BW, Shaltiel S, Stadtman ER: Determination of carbonyl content in oxidatively modified proteins. Meth Enzymol 186: 464-478, 1990
Beal MF. Oxidatively modified proteins in aging and disease. Free Radic Biol Med 32: 797-803, 2002
Levine RL. Carbonyl modified proteins in cellular regulation, aging and disease. Free Radic Biol Med 32: 790-796, 2002
Bradford MM: A rapid and sensitive method for the quantitation of microgram quantities of protein using the principle of protein-dye binding. Anal Biochem 72: 248-254, 1976
Ischiropoulos H, al Mehdi AB: Peroxynitrite-meditated oxidative protein modifications. FEBS Lett 364: 279-282, 1995
Pall ML: The levels of the nitric oxide synthase product, citrulline, as elevated in sera of chronic fatigue syndrome patients. J Chronic Fatigue Syndr 10: 37-41, 2002
Farquhar WB, Hunt BE, Taylor JA, Darling SE, Freeman R: Blood volume and its relation to peak O(2) consumption and physical activity in patients with chronic fatigue. Am J Physiol Heart Circ Physiol 282: H66-H71, 2002
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Smirnova, I.V., Pall, M.L. Elevated levels of protein carbonyls in sera of chronic fatigue syndrome patients. Mol Cell Biochem 248, 93–95 (2003). https://doi.org/10.1023/A:1024176016962
Issue Date:
DOI: https://doi.org/10.1023/A:1024176016962